Life Sciences

A chat with AstraZeneca's head of real estate and asset strategies offers a glimpse into the company's global growth strategy and focus on quality workplaces.

A new global corporate entity in animal health makes its home in Maine.

A new R&D expansion at its home base in Wisconsin is just one expression of the company’s genetic predisposition to be both conscious and growth-oriented.

Recent reports on obesity, diabetes and lifelong exercise offer looming clouds of concern and a few bright rays of encouragement.

The medical distribution giant’s global HQ will leave the Bay Area for the DFW suburb of Irving.

Among other products, the company has made cannula in the Cornhusker State for 51 years. What’s a cannula, you ask?

Major projects will improve these institutions’ already sturdy constitutions.

Recreational cannabis just turned legal in Canada two days ago. Cannabis-related firms have been building facilities in Canada for years.

If drugs are the lifeblood of the life sciences, their abuse and misuse by the workforce is a health crisis.

Emeryville welcomes renewed investment from Spain’s Grifols in a legacy site.

The 2018 edition of KPMG’s biannual overview offers pointers for entering the market and then navigating a changing landscape.

At the Montreal Neurological Institute and Hospital at McGill University, innovation is baked into the DNA.

China’s Wuxi Apptec Group is on a facility investment binge. Try to keep up.

Growth at Birmingham’s Pack Health showcases the region’s biosciences impact during the Rise of the Rest investment tour.

A mix of factors have put patients, physicians, researchers, institutes, business accelerators and even animal subjects in close physical proximity.

A detailed talent migration study by a division of the NIH is more than an academic exercise.

How is that possible in one of the nation’s costliest markets? If you’re moving from an even more expensive one.

Five years from now, a new neutron source in southern Sweden will try to give Oak Ridge a run for its money.

Real estate and economic developers find it’s good to touch the green, green grass.

Hurricane Maria hobbled drug makers in Puerto Rico. The new US tax law could hit them, too.

Israel's Teva Pharmaceuticals is cutting 14,000 jobs and $3 billion from its cost base, starting with Jerusalem.

A maker of synthetic cadavers and other simulation products for medical training experiences the excitement and growing pains that come with corporate adolescence.

Like much successful R&D, these MIT researchers' breakthrough insight was a byproduct.

Data on how often you relocate your body could be valuable to those who want to locate companies in healthy places.